πŸ‡ΊπŸ‡Έ FDA
Patent

US 11207379

Peptides with anti-cancer activity

granted A61KA61K38/17A61P

Quick answer

US patent 11207379 (Peptides with anti-cancer activity) held by IDP DISCOVERY PHARMA, S.L. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IDP DISCOVERY PHARMA, S.L.
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K38/17, A61P, A61P35/00